Deccan Herald IT Newspapers

Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan

By Isha SharmaAugust 29, 2024

The US health regulator has accepted the company’s Biologics License Application (BLA) for Bmab 1200 for review.

You may also like

IT

Google proposes these changes to comply with Europe’s Digital Markets Act

Newspapers

Homegrown Lava launches iPhone look-alike Yuva 4 smartphone at Rs 6,999: Details

IT

Redmi K80 series launches with 120Hz AMOLED display, HyperOS 2.0: Price, features, and more

IT

Redmi Note 14 launch: Xiaomi claims “It’s not the same anymore,” internet speculates price hike

Newspapers

Qualcomm Snapdragon 8s Elite processor set for 2025 launch: What to expect from Xiaomi’s next flagship

Business Standard

Fujifilm Instax Mini Link 3 teams up with Google Pixel 9 for fast-pairing and customisable photo printing

Comments are closed.

More in Deccan Herald

Deccan Herald

Musk’s Neuralink to launch feasibility trial with brain implant, robotic arm

Deccan Herald

OpenAI allows employees to sell $1.5 billion stock to SoftBank: Report

Deccan Herald

Infosys to dish out average performance bonus of 90% for Q2

Archives